血小板粘着タンパク質から派生したペプチドによるグリコプロテインIIb-IIIa複合体の関連しているが同一ではない結合部位の競争
Cell
|March 13, 1987
まとめ
2つのペプチド配列であるRGDSとHHLGGAKQAGDVは,血小板グリコプロテインIIb-IIIa複合体と結合する. これらのペプチドは同じ受容体に対して競争する一方で,グリコプロテインIIb.の異なる部位を標的とする.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 血小板生理学について
背景:
- 血小板の集積は,血液静止と血栓形成に不可欠です.
- 血小板グリコプロテインIIb-IIIa複合体は,フィブリノゲンなどの粘着性タンパク質の主要な受容体です.
- 特定のアミノ酸配列は,グリコプロテインIIb-IIIa複合体の機能を調節することができます.
研究 の 目的:
- 2つの異なるペプチド配列であるRGDSとHHLGGAKQAGDVが,血小板グリコタンパク質IIb-IIIa複合体に対する結合特性を調査する.
- これらのペプチドが受容体の同一または重複する部位に結合するかどうかを判断する.
- 各ペプチドが標的とするグリコプロテインIIb-IIIa複合体の特定のサブユニットを明らかにする.
主な方法:
- RGDSおよびHHLGGAKQAGDVペプチドの放射性標識付き,光活性化可能なアリルアジド誘導体の合成.
- これらのプローブを無傷の血小板でインキュベーションし,グリコプロテインIIb-IIIa複合体への結合を評価する.
- グリコプロテインIIbとグリコプロテインIIIaのサブユニットの特定のラベリングパターンの分析.
主要な成果:
- RGDSとHHLGGAKQAGDVペプチドは,フィブリノゲン,フィブロネクチン,フォン・ウィレブランド因子のグリコタンパク質IIb-IIIa複合体への結合を抑制した.
- それぞれのペプチド探査機は,完全無傷の血小板に,グリコプロテインIIb-IIIa複合体を特異的に標識した.
- ペプチドは,受容体複合体の結合部位を競い合い,重複または共有された結合領域を示した.
- RGDS探査機は,グリコプロテインIIbとグリコプロテインIIIaの両方のサブユニットをラベルしました.
- HHLGGAKQAGDVの探査機は,グリコプロテインIIbサブユニットだけを標識した.
結論:
- RGDSおよびHHLGGAKQAGDVペプチドは,血小板グリコプロテインIIb-IIIa複合体と結合し,受容体サイトに競争する.
- 競争にもかかわらず,これらのペプチドの結合部位は同一ではなく,異なるサブユニット特異性があります.
- HHLGGAKQAGDVペプチドは,グリコタンパク質IIbサブユニットとの特定の相互作用を示し,RGDSはIIbとIIIaの両方と相互作用する.
関連する概念動画
Ligand Binding and Linkage
4.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Selectins
3.6K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.6K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K


